Cephaloglycin: crossover absorption studies and clinical evaluation.
D001991:Bronchitis / Q000188:drug therapy*; D002509:Cephaloridine / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D002511:Cephalosporins / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D002986:Clinical Trials as Topic; D003556:Cystitis / Q000188:drug therapy*; D004304:Dosage Forms; D006801:Humans; D007408:Intestinal Absorption; D010612:Pharyngitis / Q000188:drug therapy*; D011014:Pneumonia / Q000188:drug therapy*; D011704:Pyelonephritis / Q000188:drug therapy*
D002511:Cephalosporins; D004304:Dosage Forms; D002509:Cephaloridine